Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,357,962 papers from all fields of science
Search
Sign In
Create Free Account
Randomization Documentation
Known as:
Randomiz
, Randomization Subcategory
Records pertaining to the randomization process of a clinical trial.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PD24-01 DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY OF TADALAFIL WITH DUTASTERIDE VERSUS TADALAFIL WITH PLACEBO FOR LOWER URINARY TRACTS SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA: A…
G. Tak
,
A. Singh
,
A. Ganpule
,
R. Sabnis
,
M. Desai
Journal of Urology
2019
Corpus ID: 149907069
INTRODUCTION AND OBJECTIVES: An important reason for lower urinary tract symptoms (LUTS) in elderly men is Benign Prostatic…
Expand
Review
2015
Review
2015
' s response to reviews Title : Examining the influence of a text message-based sleep and physical activity intervention among young adult smokers in the United States : a randomized controlled trial
G. Darlington
,
J. Chaput
,
Michele L. Ybarra
,
Natalie Pafitis
2015
Corpus ID: 148563868
1. In the background, it is somewhat unclear what you are examining in this pape r, with the first read through. Perhaps it would…
Expand
Review
2015
Review
2015
Trend of Hospital Performance in Northern Iran: A 5-year Assessment Using Pabon Lasso Model
S. Emamgholipour
,
A. Afkar
,
Mehrad Amin Eskandari
,
Maryam Tavakkoli
2015
Corpus ID: 86393531
Background and Objectives: The large contribution of hospitals to the function and expenditures of the healthsector makes their…
Expand
2015
2015
Phase 3 clinical Trial Evaluating 90y glass microspheres in patients with metastatic colorectal carcinoma of the liver who have failed first-line chemotherapy.
M. Karpf
2015
Corpus ID: 79268715
474 Background: Colorectal cancer (CRC) is the third most common cancer in the US. Half of pts diagnosed with CRC develop liver…
Expand
2013
2013
Use of biochar and hydrochar to reduce ammonia emissions from soils fertilized with pig slurry
R. Subedi
,
C. Kammann
,
Simone Pelissetti
,
D. Sacco
,
C. Grignani
,
S. Monaco
2013
Corpus ID: 56289116
Ammonia (NH3) volatilization caused by animal manure application to agricultural soils leads to high amounts of nitrogen (N…
Expand
2013
2013
MCSL Network-on-Chip Benchmark Suite User Manual Version 1 . 5 Mobile Computing System
2013
Corpus ID: 18392826
Network-on-chip (NoC) traffic patterns are essential tools f r NoC performance assessment and architecture exploration. The…
Expand
2012
2012
BELA trial update: Bosutinib (BOS) versus imatinib (IM) in patients (pts) with newly diagnosed chronic phase chronic myeloid leukemia (CP CML) after 30 months of follow-up.
C. Gambacorti-Passerini
,
J. Lipton
,
+7 authors
J. Byrne
2012
Corpus ID: 220744844
6512 Background: The BELA study compared the efficacy and safety of BOS (dual Src/Abl kinase inhibitor) with IM in newly…
Expand
2012
2012
Collection of Data in Secure Way in Wireless Sensor Networks
Kiran Malik
,
Sunita
2012
Corpus ID: 427161
Wireless Sensor Networks make it possible to send s cure data from source to destination. If applied to netw ork monitoring data…
Expand
2006
2006
TRAIL mediates hepatic steatosis in viral hepatitis and following alcohol intake
C. Lovegrove
Nature Clinical Practice Gastroenterology…
2006
Corpus ID: 41914150
Sacral-nerve stimulation has an overall success rate of 80% as a treatment for fecal incontinence in patients with a…
Expand
Review
2001
Review
2001
Effectiveness of Printed Patient Educational Materials in Chronic Illness:: A Systematic Review of Controlled Trials
Alan Morrison
2001
Corpus ID: 71258584
Searching MEDLINE and HealthSTAR were searched from 1965 to February 2000 for publications in the English language, using the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE